ArticleCancers2024

Genetic Testing of Breast Cancer Patients with Very Early-Onset Breast Cancer (≤30 Years) Yields a High Rate of Germline Pathogenic Variants, Mainly in the BRCA1, TP53, and BRCA2 Genes.

Paraskevi Apostolou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.